Article

Clinicopathological features and prognosis of HER2 low-expression breast cancer: a single-center retrospective study

2023-11-16

Abstract excerpt

<h4>Background: </h4> With the development of novel anti-HER2 antibody-drug conjugates, the subgroup of breast cancer patients with low HER2 expression has attracted increasing interest. The aim of this study was to investigate the clinicopathological characteristics, molecular typing and survival prognosis of patients with HER2-low breast cancer. Methods This retrospective study involved the collection of 1023 c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4880929b-7440-5281-bc60-869baaaec579
DOI: 10.21203/rs.3.rs-3610358/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinicopathological features and prognosis of HER2 low-expression breast cancer: a single-center retrospective studyDOI 10.21203/rs.3.rs-3610358/v1Read

The trichotomy of HER2 expression confers new insights into the understanding and managing for breast cancer stratified by HER2 statusSemantic proximity Read

Clinicopathological Characterization of HER2-Low-Expressing Triple-Negative Breast Cancer: Distinct Features From HER2-Zero Subtype.Semantic proximity Read

Impact of HER2-low Breast Cancer on Survival in Denmark: A Nationwide Investigation (2007-2019)Semantic proximity Read

Unveiling the mysteries of HER2-low expression in breast cancer: pathological response, prognosis, and expression level alterationsSemantic proximity Read

[Biological characteristics of triple negative breast cancer with low expression of HER2].Semantic proximity Read

Prognostic Value of HER2-Low Expression in Non-Metastatic Triple-Negative Breast Cancer and Correlation with Other BiomarkersSemantic proximity Read

Clinical Significance and Genetic Characteristics in HER2 Low Expression Tumors of Hormone Receptor Positive Breast Cancer PatientsSemantic proximity Read

Do HER2-Low Tumors Have a Distinct Clinicopathologic Phenotype?Semantic proximity Read

HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast CancerSemantic proximity Read

Molecular and clinical traits of HER2-low breast cancer patients and their relationship with neoadjuvant treatment effectiveness.Semantic proximity Read

Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancerSemantic proximity Read

Low and Ultra-low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic SubtypesSemantic proximity Read